Protecting IP While Complying with AI Transparency Laws
Transparency vs. Trade Secrets: How to satisfy CA regulators without giving away the farm. 🏰
The Tension
For many AI companies, their dataset is their moat. You may have spent millions licensing proprietary medical images or curating a unique dataset of patient interactions. Now, California's AB 2013 wants you to describe that data to the public.
The fear is real: If you disclose too much, competitors could replicate your dataset. If you disclose too little, you face regulatory fines.
Strategies for Safe Disclosure
1. Use Broad Categories
The law asks for a "high-level summary." You can satisfy this by using broad, descriptive categories rather than specific file lists.
- Instead of: "15,000 chest X-rays from St. Mary's Hospital, 2020-2023."
- Use: "De-identified chest radiographs from multiple US-based acute care facilities."
2. Focus on Data Types, Not Sources
Describe what the data is (e.g., "clinical notes," "lab values") rather than where exactly it came from, unless the source is public (like PubMed).
3. Aggregate Statistics
Provide aggregate stats that show the scale and diversity of the data without revealing the "secret sauce" of your curation process. "Over 1 million patient encounters representing diverse demographics" is a strong disclosure that protects IP.
Legal Review
Have your IP counsel review your transparency disclosures before they go live. Ensure you aren't inadvertently waiving trade secret protection by over-disclosing. Your disclosure should be drafted as carefully as a patent application.
Conclusion
Compliance is an art. Disclose what is required to inform the public and regulators, but protect the specific details that give your company its competitive edge.
Frequently Asked Questions (FAQ)
Can I claim "Trade Secret" to avoid disclosing anything?
No. AB 2013 does not have a broad "trade secret" exemption that allows you to opt-out entirely. You must provide the summary. The art is in how you write the summary.
What if my competitors copy my data strategy based on my disclosure?
This is a risk. However, knowing what data you used is different from having access to the data itself. Focus on protecting the access to your proprietary sources.
Does this apply to synthetic data I generated?
Yes. You should disclose that you used synthetic data and describe how it was generated (e.g., "Synthetic patient profiles generated using a statistical model based on public census data").